ArticleMolecules (Basel, Switzerland)2019
Engineering the Enantioselectivity of Yeast Old Yellow Enzyme OYE2y in Asymmetric Reduction of (
Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Using Data Science for Mechanistic Insights and Selectivity Predictions in a Non-Natural Biocatalytic Reaction.Journal of the American Chemical Society · 2023Article
- Engineering aRSC advances · 2023Article
- Design and engineering of whole-cell biocatalyst for efficient synthesis of (R)-citronellal.Microbial biotechnology · 2022Article
- Tunable Production of (ACS catalysis · 2022Article
- "A Study in Yellow": Investigations in the Stereoselectivity of Ene-Reductases.Chembiochem : a European journal of chemical biology · 2022Review
- Engineering of Yeast Old Yellow Enzyme OYE3 Enables Its Capability Discriminating of (Molecules (Basel, Switzerland) · 2021Article
- Enzymes, Biocatalysis and Chemical Biology.Molecules (Basel, Switzerland) · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
The members of the Old Yellow Enzyme (OYE) family are capable of catalyzing the asymmetric reduction of (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.